AMBEA

127.6

-0.23%↓

AMBEA

127.6

-0.23%↓

AMBEA

127.6

-0.23%↓

AMBEA

127.6

-0.23%↓

AMBEA

127.6

-0.23%↓

Search

RaySearch Laboratories AB

Chiusa

224.5 -1.32

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

224

Massimo

232.5

Metriche Chiave

By Trading Economics

Entrata

32M

72M

Vendite

27M

332M

P/E

Media del settore

36.129

105.69

EPS

2.09

Rendimento da dividendi

1.29

Margine di Profitto

21.547

Dipendenti

416

EBITDA

-38M

36M

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

1.29%

2.37%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-2.3B

7.6B

Apertura precedente

225.82

Chiusura precedente

224.5

RaySearch Laboratories AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 nov 2025, 18:59 UTC

I principali Market Mover

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17 nov 2025, 23:40 UTC

Discorsi di Mercato

Gold Consolidates Amid Mixed Signals -- Market Talk

17 nov 2025, 23:34 UTC

Discorsi di Mercato

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17 nov 2025, 22:58 UTC

Discorsi di Mercato

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17 nov 2025, 22:46 UTC

Discorsi di Mercato

Risk Assets Set to Have a Strong 2026 -- Market Talk

17 nov 2025, 22:06 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17 nov 2025, 22:02 UTC

Utili

Trip.com Group 3Q Rev $2.6B >TCOM

17 nov 2025, 22:02 UTC

Utili

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17 nov 2025, 22:02 UTC

Utili

Trip.com Group 3Q EPS $4.02 >TCOM

17 nov 2025, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

17 nov 2025, 21:40 UTC

Utili

James Hardie Industries 2Q Adj EPS 26c >JHX

17 nov 2025, 21:40 UTC

Utili

James Hardie Industries 2Q Loss/Shr 10c >JHX

17 nov 2025, 21:39 UTC

Utili

James Hardie Industries 2Q Sales $1.29B >JHX

17 nov 2025, 21:38 UTC

Utili
Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 21:38 UTC

Utili

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17 nov 2025, 21:10 UTC

Utili

XP Inc. 3Q EPS BRL2.47 >XP

17 nov 2025, 21:10 UTC

Utili

XP Inc. 3Q Rev BRL4.67B >XP

17 nov 2025, 20:20 UTC

Discorsi di Mercato

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17 nov 2025, 20:12 UTC

Discorsi di Mercato

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17 nov 2025, 20:12 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

17 nov 2025, 20:09 UTC

Discorsi di Mercato

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17 nov 2025, 19:29 UTC

Discorsi di Mercato

Gold Slide Continues to Start Week -- Market Talk

17 nov 2025, 19:16 UTC

Utili
Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 18:20 UTC

Acquisizioni, Fusioni, Takeovers

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17 nov 2025, 16:45 UTC

Acquisizioni, Fusioni, Takeovers

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17 nov 2025, 16:16 UTC

Utili
Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 16:15 UTC

Utili

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17 nov 2025, 15:40 UTC

Acquisizioni, Fusioni, Takeovers

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17 nov 2025, 15:22 UTC

Acquisizioni, Fusioni, Takeovers

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17 nov 2025, 15:19 UTC

Discorsi di Mercato

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Confronto tra pari

Modifica del prezzo

RaySearch Laboratories AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) is headquartered in Stockholm, Sweden.
help-icon Live chat